Drug intelligence / Profile preview

gallium Ga 68 N188

Development stage
Phase 1
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
Administration
Intravenous
01

Overview

Gallium Ga 68 N188 is a radiopharmaceutical composed of a nectin-4-targeting bicyclic peptide (N188) labeled with the positron-emitting radioisotope gallium-68. It is designed for use in PET/CT imaging to noninvasively quantify membranous nectin-4 expression in tumors. The agent binds specifically to nectin-4 (poliovirus receptor-like protein 4; PVRL4), an emerging biomarker overexpressed in several cancers including urothelial carcinoma, pancreatic cancer, intrahepatic cholangiocarcinoma, cervical cancer, and hepatocellular carcinoma. By visualizing and quantifying nectin-4 expression levels in vivo, [68Ga]N188 can help stratify patients for therapies targeting nectin-4 (such as enfortumab vedotin) and may assist with staging or restaging disease. Preclinical and clinical studies have demonstrated high affinity for nectin-4 and favorable pharmacokinetics and safety profiles[1][2][5][4].

Other names
gallium Ga-68 N188[^68Ga]N188
02

Targets

PVRL4 (Nectin cell adhesion molecule 4)

Beyond the preview

Go deeper on gallium Ga 68 N188.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gallium Ga 68 N188.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call